BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18566970)

  • 1. Stem cell factor as a novel diagnostic marker for early malignant germ cells.
    Stoop H; Honecker F; van de Geijn GJ; Gillis AJ; Cools MC; de Boer M; Bokemeyer C; Wolffenbuttel KP; Drop SL; de Krijger RR; Dennis N; Summersgill B; McIntyre A; Shipley J; Oosterhuis JW; Looijenga LH
    J Pathol; 2008 Sep; 216(1):43-54. PubMed ID: 18566970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
    Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
    Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
    Looijenga LH
    J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men.
    Hoei-Hansen CE
    Cancer Treat Rev; 2008 Jun; 34(4):348-67. PubMed ID: 18289797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the PDGF alpha-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms.
    Palumbo C; van Roozendaal K; Gillis AJ; van Gurp RH; de Munnik H; Oosterhuis JW; van Zoelen EJ; Looijenga LH
    J Pathol; 2002 Apr; 196(4):467-77. PubMed ID: 11920744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).
    Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH
    J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours.
    de Jong J; Stoop H; Dohle GR; Bangma CH; Kliffen M; van Esser JW; van den Bent M; Kros JM; Oosterhuis JW; Looijenga LH
    J Pathol; 2005 Jun; 206(2):242-9. PubMed ID: 15818593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
    Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells.
    Jørgensen N; Rajpert-De Meyts E; Graem N; Müller J; Giwercman A; Skakkebaek NE
    Lab Invest; 1995 Feb; 72(2):223-31. PubMed ID: 7531795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
    Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
    Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development.
    Honecker F; Kersemaekers AM; Molier M; Van Weeren PC; Stoop H; De Krijger RR; Wolffenbuttel KP; Oosterhuis W; Bokemeyer C; Looijenga LH
    J Pathol; 2004 Oct; 204(2):167-74. PubMed ID: 15378486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor risk in disorders of sex development (DSD).
    Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells.
    Honecker F; Stoop H; de Krijger RR; Chris Lau YF; Bokemeyer C; Looijenga LH
    J Pathol; 2004 Jul; 203(3):849-57. PubMed ID: 15221945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
    Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
    J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
    Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
    Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
    Rajpert-De Meyts E
    Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2gamma in semen samples: case report.
    Hoei-Hansen CE; Rajpert-De Meyts E; Carlsen E; Almstrup K; Leffers H; Skakkebaek NE
    Hum Reprod; 2005 Mar; 20(3):579-82. PubMed ID: 15650041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory.
    van Casteren NJ; de Jong J; Stoop H; Steyerberg EW; de Bekker-Grob EW; Dohle GR; Oosterhuis JW; Looijenga LH
    Int J Androl; 2009 Dec; 32(6):666-74. PubMed ID: 18798762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in alkaline phosphatase isozyme expression in human testicular germ cell tumours: An enzyme-/immunohistochemical and molecular analysis.
    Roelofs H; Manes T; Janszen T; Millán JL; Oosterhuis JW; Looijenga LH
    J Pathol; 1999 Oct; 189(2):236-44. PubMed ID: 10547581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas.
    Biermann K; Klingmüller D; Koch A; Pietsch T; Schorle H; Büttner R; Zhou H
    Histopathology; 2006 Sep; 49(3):290-7. PubMed ID: 16918976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.